Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from iex and EODHD
Download Data

Arcadia Biosciences Inc Income Statement 2012 - 2024

This table shows the Income Statement for Arcadia Biosciences Inc going from 2012 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2012-12-31
Revenue
M 1 1 2 1 2 1 2 4 3 2 2 1 1 7 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 2 1 1 3 2 1 1 2 2 7
Cost of Revenue
M 1 1 1 1 1 2 1 3 3 4 3 2 1 2 2 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 2 0 0 0 0 1
Gross Profit
M 0 1 0 0 1 -1 1 0 0 -2 0 0 0 5 -2 -1 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 1 1 1 2 1 1 3 0 1 1 2 2 -
Operating Expenses
M 3 4 4 4 5 5 5 5 4 12 9 8 5 -2 6 6 6 4 6 5 5 5 4 5 4 4 4 5 5 5 5 5 6 5 6 5 4 4 6 6 4 4 4 -
Selling, General, and Administrative Expenses (SG&A)
M 3 3 3 4 4 4 5 5 4 5 6 6 5 5 4 4 4 3 4 3 3 3 3 3 3 2 2 3 3 3 3 3 3 3 3 3 3 2 2 4 2 2 2 16
Research and Development (R&D) Expenses
M 0 0 0 0 0 1 0 0 0 1 1 1 1 2 2 2 2 2 2 2 2 2 1 2 1 2 2 2 2 2 2 2 2 2 3 2 2 2 4 2 2 2 2 8
Other Operating Expenses
M 0 0 0 0 0 1 0 0 0 7 1 0 -1 -9 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Costs and Expenses
M 3 3 3 3 4 3 4 2 1 3 5 6 4 5 4 4 6 4 6 5 4 4 4 4 4 4 4 4 5 5 5 5 5 4 6 5 4 4 4 6 4 4 4 -
Operating Income
M -3 -3 -3 -4 -4 -6 -5 -5 -5 -14 -9 -8 -5 7 -8 -7 -6 -4 -6 -5 -4 -4 -4 -5 -4 -3 -4 -4 -4 -5 -4 -4 -5 -4 -4 -4 -4 -2 -6 -5 -3 -2 -3 -
Interest Expense
M - 0 - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 1 1 1 4 0 2 2 1 0 -1 5 2 7 10 0 -3 8 -1 -8 10 4 4 9 0 -6 0 -1 0 0 0 0 0 0 1 0 1 -1 0 -1 0 0 0 0 -
EBT
M -2 -3 -2 1 -4 -4 -3 -4 -5 -10 -3 -5 2 8 -7 -10 2 -6 -14 4 -1 -1 4 -7 -11 -3 -5 -4 -4 -6 -4 -5 -5 -4 -5 -4 -6 -2 -7 -5 -3 -3 -3 -
Income Tax Provision
M - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M - -3 -3 1 -4 -4 -3 -4 -4 -10 -3 -5 2 9 -7 -10 2 -6 -14 4 -1 -1 4 -7 -11 -3 -5 -4 -4 -6 -4 -5 -5 -4 -5 -4 -6 -2 -7 -5 -3 -3 -3 -
Non-Controlling Interest
M - - - 0 5 5 0 0 0 0 -1 0 0 0 -1 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 4 0 0 0 0 - -
Net Income
M - - - 1 -9 -9 -3 -4 -4 -9 -2 -5 2 9 -6 -10 3 -6 -14 4 -13 -1 4 -7 -11 -3 -5 -4 -4 -6 -4 -5 -5 -4 -5 -5 -8 -22 0 0 0 0 - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 1,361,657.00 1,285,337.00 1,359,511.00 1,358,395.00 864,391.00 599,389.00 613,813.00 554,722.00 554,674.00 22,177,423.00 554,435.00 543,635.00 476,074.00 10,719,618.00 267,990.00 233,182.00 216,865.00 8,651,213.00 173,565.00 126,370.00 4,776,540.00 4,776,540.00 119,368.00 82,691.00 54,654.00 2,186,196.00 53,346.00 53,331.00 55,450.00 2,218,009.00 55,462.00 55,385.00 55,268.00 55,138.00 54,558.00 29,719.00 47,545.00 1,901,837.00 40,900.00 40,900.00 40,900.00 1,636,018.00 2,160,000.00 -
EBITDA
M -3 -3 -3 -8 -4 -6 -6 -5 -5 -8 -7 -5 2 8 -8 -7 -6 -5 -6 -14 -8 -4 -4 -4 -2 -3 -4 -4 -4 -5 -4 -4 -5 -3 -4 -4 -5 -2 -7 -5 -3 -2 -4 -
Depreciation and Amortization
M 0 0 0 0 0 0 -2 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -3 -3 -3 -8 -4 -6 -5 -5 -5 -8 -7 -5 1 8 -9 -7 -6 -5 -6 -14 -8 -4 -4 -4 -2 -3 -4 -4 -4 -5 -4 -4 -5 -3 -4 -4 -5 -2 -7 -5 -3 -2 -4 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Tax Rate (Effective)
% - -0.27 -3.34 0.12 4.89 -0.30 -0.03 0.53 2.93 -0.01 -0.04 2.97 -22.43 -1.64 -0.13 0.10 0.70 0.19 0.02 -0.02 2.42 2.42 0.11 -0.17 -0.09 0.17 -0.29 -0.20 -0.24 -0.02 -0.17 -0.24 -0.12 4.84 2.06 -2.51 -4.11 -1.43 -0.61 -1.91 -3.11 -1.42 -1.79 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Gross Profit Margin
% 34.66 42.74 31.00 29.37 45.33 -55.20 28.43 10.65 -7.39 -72.92 -5.68 -12.95 -3.38 75.65 -486.31 -430.25 57.28 -34.86 54.85 56.16 48.20 48.20 66.49 37.84 83.18 98.53 93.21 88.29 89.59 -20.93 94.42 95.15 82.75 50.30 96.65 92.59 93.13 97.68 -19.51 96.48 93.39 95.65 95.05 -
Operating Income Margin
% -241.12 -278.21 -203.01 -272.93 -268.26 -583.00 -242.60 -119.23 -143.57 -635.84 -366.71 -546.76 -643.24 104.75 -2,414.33 -2,446.98 -1,873.79 -958.89 -1,579.85 -2,453.69 -980.63 -980.63 -1,107.84 -1,050.00 -1,793.93 -210.08 -613.75 -377.09 -389.29 -1,013.15 -365.30 -594.87 -578.99 -302.38 -232.31 -248.04 -455.34 -58.26 -395.67 -383.07 -187.51 -113.24 -145.60 -
Net Income Margin
% - - - 59.25 -621.87 -938.40 -152.66 -97.90 -139.38 -427.54 -91.54 -374.45 248.55 124.80 -2,035.35 -3,448.04 817.15 -1,500.96 -3,619.13 2,087.68 -2,840.54 -145.50 1,202.70 -1,529.59 -4,960.28 -207.28 -768.25 -404.24 -414.15 -1,057.04 -388.37 -631.21 -609.15 -286.55 -253.37 -318.60 -944.17 -789.03 0.00 0.00 0.00 0.00 - -
EBITDA Ratio
% -222.95 -259.23 -203.01 -587.04 -270.78 -594.50 -336.63 -136.75 -149.25 -378.77 -302.53 -330.75 204.59 117.71 -2,631.53 -2,388.26 -1,826.54 -1,155.53 -1,620.92 -7,103.45 -1,848.20 -973.65 -1,065.14 -916.74 -881.78 -203.15 -594.23 -360.04 -381.34 -980.74 -349.49 -573.23 -571.13 -235.74 -212.89 -248.04 -617.79 -54.61 -443.87 -376.25 -182.21 -108.14 -203.85 -
EBIT Ratio
% -241.12 -278.21 -208.58 -591.86 -268.26 -583.00 -242.60 -119.23 -143.57 -388.39 -315.32 -350.39 173.67 113.97 -2,782.48 -2,426.69 -1,850.49 -1,170.19 -1,635.20 -7,124.63 -1,855.18 -980.63 -1,071.89 -927.29 -906.07 -207.63 -605.94 -366.60 -389.29 -995.00 -356.93 -584.33 -578.99 -241.98 -216.68 -252.87 -626.63 -57.68 -449.80 -383.07 -189.03 -113.24 -209.89 -
EBT Ratio
% -193.07 -223.59 -155.54 58.96 -268.26 -431.50 -153.14 -98.42 -143.17 -440.17 -119.32 -385.91 203.02 118.78 -2,278.98 -3,524.56 789.64 -1,519.95 -3,619.90 2,087.19 -149.10 -149.10 1,204.05 -1,527.06 -4,955.61 -207.63 -766.04 -403.43 -413.16 -1,056.85 -387.72 -629.68 -608.45 -301.11 -258.69 -250.84 -683.93 -70.05 -467.44 -396.63 -216.92 -126.62 -153.30 -

StockViz Staff

September 8, 2024

Any question? Send us an email